Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30% individuals globally.
As the low carbon transition of power systems accelerates, low carbon demand response, characterized by both environmental orientation and behavioral incentives, has become a key mechanism for ...